Media
-
Join us at CPhI Japan 2024, where the world of pharmaceuticals converges to explore innovation, collaboration, and growth opportunities!!!!
Apr 08, 2024
-
We are delighted to inform you that we have received CEP approval for Rivaroxaban, which is used as an anti-coagulating agent,
Apr 08, 2024
-
We are excited to meet our business associates and partners in the DCAT Week in the New York City!!!
Mar 18, 2024
-
We're thrilled to announce that we received CEP approval for Gliclazide. With this approval, we're one step closer
Mar 01, 2024
-
The "15th Asia Pharma Expo" in Dhaka, Bangladesh, is opening today, providing an opportunity to network
Mar 01, 2024
-
We're thrilled to announce the successful filing of the USDMF for Sitagliptin Phosphate Monohydrate! This milestone represents a significant step
Jan 23, 2024
-
Ami Lifesciences family blissfully celebrates the divine homecoming of Lord Ram in Ayodhya with heartfelt prayers and Shobha Yatra.
Jan 23, 2024
-
We are excited to announce the US DMF submission of Mirogablin Besylate to the US FDA.
Jan 01, 2024
-
As we say goodbye to 2023, we pause to reflect on our team's accomplishments. This year has prove.
Jan 01, 2024
-
We will be exhibiting at CPHI & PMEC India PMEC at India Expo Centre & Mart, Greater Noida on November 28-30, 2023.
Nov 22, 2023
-
You are cordially invited to attend CPHI Barcelona 2023 and meet our emerging markets team. We're thrilled to have you in this exclusive space
Oct 17, 2023
-
Mark your calendar to connect with our team at CPHI Barcelona, 2023. Seize the chance to launch ground-breaking collaborative projects.
Oct 17, 2023
-
Join us at CPHI Barcelona from October 24th to 26th!!! Team Ami is excited to welcome you to this vibrant platform and world's
Oct 17, 2023
-
At CPhI Worldwide 2023, the pharmaceutical industry will congregate in Barcelona, and Ami Lifesciences will be leading the charge.
Oct 11, 2023
-
We are thrilled to announce that the USDMF for Finerenone has been submitted to the USFDA; this is the first USDMF for Finerenone API from an Indian
Sep 29, 2023
-
Congratulations to team Ami Lifesciences for being shortlisted as a finalist for the Regulatory Achievement of the Year award at the Global Generics
Sep 28, 2023
-
We will be exhibiting at CPHI Barcelona, 2023, the world's leading pharmaceutical and healthcare exhibition!
Meet our team at booth no. 81C40 during the event.Sep 20, 2023
-
We are very grateful to all our clients and visitors for their time and meaningful discussion during the meetings at PharmaConex 2023.
Sep 08, 2023
-
It's time to say CPhI Korea 2023
Our team is grateful to all the customers and visitors for the meaningful meetings and discussions at our booth.Sep 01, 2023
-
Ami Lifesciences is pleased to announce that it will be exhibiting at CPHI Korea at COEX in Seoul from August 30 to September 1 at booth No. G38B.
Sep 01, 2023
-
We are delighted to announce the successful CADIFA submission of Bempedoic Acid to ANVISA, Brazil. For this API, we are fully backward-integrated
Sep 01, 2023
-
Ami Lifesciences will be exhibiting at Pharmaconex 2023, to be held from September 3 to 5, 2023 at the Egypt International Exhibition Centre in Cairo.
Aug 28, 2023
-
Ami Lifesciences is pleased to announce that it will be exhibiting at CPHI Korea from August 30 to September 1 at COEX in Seoul at booth No. G38B
Aug 22, 2023
-
We are thrilled to announce Ami Lifesciences being the Highest USDMF filer (#14) in H-1 2023 timeframe Globally.
Aug 21, 2023
-
We are delighted to announce that the USDMF for Daprodustat API has been filed with the US FDA.
June 30, 2023
-
Yoga is the fountain of youth. It's exercise, meditation, and philosophy rolled into one.
June 26, 2023
-
Sneak peek of our team at China CPHI, connecting with clients, business partners
June 26, 2023
-
We are happy to be back in China and exhibiting at CPHI China from June 19-21, 2023.
June 19-21, 2023
-
CPHI North America was a success for Ami Lifesciences Pvt Ltd. We appreciate our clients and guests stopping
April 25 to 27, 2023.
-
We are exhibiting at CPHI North America, and you are welcome to visit the Ami Lifesciences
April 25 to 27, 2023.
-
We are pleased to inform that we are now EcoVadis Certified, the most widely recognized international
20 April 2023
-
We are excited to be at CPhI Japan (19-21 April 2023). It will be a pleasure to meet our customers
10 April 2023
-
We will be exhibiting at the CPHI North America Exhibition in Pennsylvania from April 25th to 27th, 2023.
10 April 2023
-
The USDMF for Empagliflozin API submitted to the USFDA. Our expert team created and scaled up a lean process to assist our formulation partners
27 Mar 2023
-
Ami Lifesciences had a very successful DCAT Week, with significant customer meetings and anticipating an incredible path forward.
27 Mar 2023
-
We are pleased to inform you that the USDMF for Edoxaban API has been submitted to the USFDA. Based on our process expertise
27 Mar 2023
-
Mr Varad Nabar, AVP Marketing, will attend DCAT (Drug, Chemical & Associated Technologies Association) Week 2023 in New York
20 - 23 Mar 2023
-
The DCAT (Drug, Chemical & Associated Technologies Association) week is approaching; come meet us and learn more about Ami Lifesciences
20 - 23 Mar 2023
-
Our CEO, Amit Kaptain, will be in New York from March 20th to 23rd for DCAT (Drug, Chemical & Associated Technologies Association) Week 2023.
20 - 23 Mar 2023
-
It gives us great pleasure to announce that the USDMF for Sacubitril Sodium has been submitted to the USFDA. With an innovative development strategy, our team of experts
20 Mar 2023
-
Our innovation efforts have been validated today when our R&D team received Excellence in Research and Development" award.
20 Mar 2023
-
We are pleased to inform you that Sacubitril Valsartan's USDMF has been successfully submitted to the USFDA. Our process experts developed Sacubitril Valsartan
09 Mar 2023
-
We are pleased to announce that the USDMF for Desvenlafaxine Succinate has been submitted to the USFDA.
08 Mar 2023
-
We are glad to share that the US DMF for Sevelamer Hydrochloride was successfully submitted to the USFDA. We have a distinctive advantage
02 Mar 2023
-
We are happy to announce our USDMF filing of Dapagliflozin Amorphous to the USFDA.
02 Mar 2023
-
We are extremely happy to share the successful filling of Febuxostat USDMF with the USFDA.
18 Feb 2023
-
We are happy to share that the US DMF for Sevelamer Carbonate was successfully submitted to the USFDA.
17 Feb 2023
-
We are delighted to announce that the USDMF for Tadalafil was successfully submitted to the USFDA.
17 Feb 2023
